Gongyu Yang, MD | |
1425 N Randall Rd, Elgin, IL 60123-2300 | |
(847) 429-8998 | |
Not Available |
Full Name | Gongyu Yang |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 40 Years |
Location | 1425 N Randall Rd, Elgin, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144282674 | NPI | - | NPPES |
036103672 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 036103672 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Advocate Sherman Hospital | Elgin, IL | Hospital |
University Of Illinois Hospital | Chicago, IL | Hospital |
Central Dupage Hospital | Winfield, IL | Hospital |
Northwestern Medicine Mchenry Hospital | Mchenry, IL | Hospital |
Presence Saint Joseph Hospital - Elgin | Elgin, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Integrated Imaging Consultants Llc | 2567784408 | 166 |
The Board Of Trustees Of The University Of Illinois | 3072422716 | 929 |
News Archive
A new stem cell study has raised hopes for therapy in Parkinson's disease. Researchers said they have, for the first time, generated stem cells from one of the most rapidly-progressing forms of the disease. They said the development will boost research into the condition because it will allow scientists to model the disease in laboratories and help them shed light on why certain nerve cells die. The research was led by the University of Edinburgh in collaboration with University College London (UCL).
BioMedTracker, a product of Sagient Research Systems, the leading provider of competitive intelligence and investment analytics on the biotech/pharmaceutical sector, today announced the recent launch of its new service, Thought Leader Opinions (TLO). This service provides its subscribers with direct access to the latest expert opinions in the disease areas that they follow within the intuitive BioMedTracker drug information platform.
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
› Verified 2 days ago
Entity Name | The Board Of Trustees Of The University Of Illinois |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
A new stem cell study has raised hopes for therapy in Parkinson's disease. Researchers said they have, for the first time, generated stem cells from one of the most rapidly-progressing forms of the disease. They said the development will boost research into the condition because it will allow scientists to model the disease in laboratories and help them shed light on why certain nerve cells die. The research was led by the University of Edinburgh in collaboration with University College London (UCL).
BioMedTracker, a product of Sagient Research Systems, the leading provider of competitive intelligence and investment analytics on the biotech/pharmaceutical sector, today announced the recent launch of its new service, Thought Leader Opinions (TLO). This service provides its subscribers with direct access to the latest expert opinions in the disease areas that they follow within the intuitive BioMedTracker drug information platform.
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
› Verified 2 days ago
Entity Name | Integrated Imaging Consultants Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700285335 PECOS PAC ID: 2567784408 Enrollment ID: O20141204001441 |
News Archive
A new stem cell study has raised hopes for therapy in Parkinson's disease. Researchers said they have, for the first time, generated stem cells from one of the most rapidly-progressing forms of the disease. They said the development will boost research into the condition because it will allow scientists to model the disease in laboratories and help them shed light on why certain nerve cells die. The research was led by the University of Edinburgh in collaboration with University College London (UCL).
BioMedTracker, a product of Sagient Research Systems, the leading provider of competitive intelligence and investment analytics on the biotech/pharmaceutical sector, today announced the recent launch of its new service, Thought Leader Opinions (TLO). This service provides its subscribers with direct access to the latest expert opinions in the disease areas that they follow within the intuitive BioMedTracker drug information platform.
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Gongyu Yang, MD 34659 Eagle Way, Chicago, IL 60678-1346 Ph: (847) 676-0091 | Gongyu Yang, MD 1425 N Randall Rd, Elgin, IL 60123-2300 Ph: (847) 429-8998 |
News Archive
A new stem cell study has raised hopes for therapy in Parkinson's disease. Researchers said they have, for the first time, generated stem cells from one of the most rapidly-progressing forms of the disease. They said the development will boost research into the condition because it will allow scientists to model the disease in laboratories and help them shed light on why certain nerve cells die. The research was led by the University of Edinburgh in collaboration with University College London (UCL).
BioMedTracker, a product of Sagient Research Systems, the leading provider of competitive intelligence and investment analytics on the biotech/pharmaceutical sector, today announced the recent launch of its new service, Thought Leader Opinions (TLO). This service provides its subscribers with direct access to the latest expert opinions in the disease areas that they follow within the intuitive BioMedTracker drug information platform.
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
› Verified 2 days ago
Jeffrey P Shafer, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 77 N Airlite Street, Elgin, IL 60123 Phone: 847-931-5520 Fax: 847-695-3319 | |
Brian Schwartz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 77 N Airlite St, Elgin, IL 60123 Phone: 847-695-3200 Fax: 847-695-8815 | |
Rotimi Johnson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2385 Bowes Rd Ste 350, Elgin, IL 60123 Phone: 847-429-2091 Fax: 847-429-2440 | |
Amitabh Singh, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 934 Center St, Elgin, IL 60120 Phone: 847-429-8998 | |
Michael J Smith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1425 N Randall Rd, Elgin, IL 60123 Phone: 224-783-6873 | |
Lee Green, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 934 Center St, Elgin, IL 60120 Phone: 847-429-8998 |